IVC and Cancer

In the early 1990s, the National Cancer Institute (NCI), a division of the National Institutes of Health (NIH), released research examining the use of intravenous Vitamin C (IV-C) in cancer treatment. This was significant for several reasons, particularly because it represented federal funding being directed toward the study of a natural therapy and its potential role in oncology care. Researchers were interested in how high-dose Vitamin C might improve the effectiveness of chemotherapy while also helping to reduce some of the difficult side effects experienced by patients undergoing treatment.

For many years following that initial research, little public attention was given to IV Vitamin C in cancer care. Approximately 15 years later, however, researchers at the University of Kansas began studying the use of IV Vitamin C in ovarian cancer patients and reported encouraging findings. Grant funding supported additional investigation into the relationship between IV-C and chemotherapy, and researchers observed that administering IV Vitamin C prior to chemotherapy treatments appeared to reduce many chemotherapy-related side effects, including fatigue, nausea, vomiting, diarrhea, pain, hair loss, and weight loss.

Discussions with researchers familiar with the University of Kansas studies suggested that IV Vitamin C may also help improve the effectiveness of chemotherapy in cancer regression. Some researchers believed that, in the future, this supportive approach might even allow for lower doses of chemotherapy while still achieving beneficial clinical outcomes, as Vitamin C appeared to enhance chemotherapy response while significantly improving treatment tolerance.

I recently spoke with a woman diagnosed with advanced colon cancer who was extremely fearful that chemotherapy would either destroy her quality of life or potentially shorten it further. After exhausting many of her options, she proceeded with chemotherapy while also receiving high-dose IV Vitamin C prior to treatment sessions. According to her experience, she tolerated treatment remarkably well. She reported excellent energy levels, no hair loss, and an overall sense of well-being during therapy. Most importantly, her scans reportedly showed that the cancer had nearly disappeared. She described IV Vitamin C as having been tremendously helpful throughout her treatment journey. Interestingly, she mentioned that her oncologist did not actively discuss the Vitamin C treatments because it was not part of their standard treatment protocol, although they were reportedly very impressed by how well she responded.

Additional institutions, including the University of Iowa, have also explored IV Vitamin C in cancer patients following the encouraging findings from earlier federally funded and university-supported research.

Researchers at the University of Kansas also emphasized an important distinction between oral and intravenous Vitamin C. While oral supplementation may provide general health benefits, it cannot achieve the extremely high blood concentrations believed necessary for therapeutic purposes in oncology support. Those concentrations can only be reached through intravenous administration.

As a final example, I once received a call from an oncologist regarding a patient whose body had become severely depleted from ongoing chemotherapy treatments. The physician expressed concern that continuing chemotherapy without additional supportive care could seriously compromise the patient’s health. The oncologist asked whether IV Vitamin C could be used to help strengthen the patient enough to continue treatment safely. After beginning IV-C therapy, the patient reportedly regained strength, improved overall well-being, and was ultimately able to complete the chemotherapy protocol.

While IV Vitamin C is not considered a cure for cancer and continues to be studied as an integrative or supportive therapy, growing interest among researchers and some oncology professionals suggests it may offer meaningful support for certain patients undergoing conventional cancer treatment.

– John Young, M.D.

727-545-4600 YoungFoundationalHealth.com